Iron absorption in erythropoietin-treated haemodialysis patients: Effects of iron availability, inflammation and aluminium

Nephrology Dialysis Transplantation

Volumn 13, Issue 1, 1998, Pages 82-88

  Kooistra, Menno P ^a,d   Niemantsverdriet, Eveline C ^a   Van Es, Ad ^b   Mol Beermann, Noor M ^b   Struyvenberg, Albert ^a   Marx, Joannes J M ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Ziekenhuis Hilversum   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d Stichting Thuisdialyse Midden W N   (Netherlands)

Author keywords

Anaemia; Erythropoietin; Haemodialysis; Iron absorption

Indexed keywords

ALUMINUM; ALUMINUM HYDROXIDE; C REACTIVE PROTEIN; DEFEROXAMINE; FERRITIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; IRON ABSORPTION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON METABOLISM; IRON THERAPY; ISOTOPE LABELING; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL;

ABSORPTION; ADULT; AGED; AGED, 80 AND OVER; ALUMINUM; C-REACTIVE PROTEIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRITINS; HUMANS; INFLAMMATION; IRON; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0031962827     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.1.82     Document Type: Article

References (24)

1. Eschbach JW. The anemia of chronic renal failure: pathophysiology and the effects of recombinant human erythropoietin. Kidney Int 1989; 35: 134-148
2. Macdougall IC. Poor response to erythropoietin: practical guidelines on investigation and management. Nephrol Dial Transplant 1995; 10: 607-614
3. Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 1986; 2: 1175-1178
4. Eschbach JW, Egrie JC, Downing MR, Brown JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316: 73-78
5. Van Wijck DB. Iron management during recombinant human erythropoietin therapy. Am J Kidney Dis 1989; 14 [suppl. 1]: 9-13
6. Macdougall IC, David Hutton R, Cavill I, Coles GA, Williams JD. Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously. Br Med J 1989; 299: 157-158
7. Sunder-Plassmann G, Hörl WH. Importance of iron supply for erythropoietin therapy. Nephrol Dial Transplant 1995; 10: 2070-2076
8. Kooistra MP, van Es A, Struyvenberg A, Marx JJM. Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin. Br J Haematol 1991; 79: 634-639
9. Marx JJM. Mucosal uptake, mucosal transfer and retention of iron, measured by whole body counting. Scand J Haematol 1979; 23: 293-302
10. De Broe ME, Drüecke TB, Ritz E. Consensus conference - diagnosis and treatment of aluminium overload in end-stage renal failure patients. Nephrol Dial Transplant 1993; 8 [Suppl 1]: 1-4
11. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood 1990; 75: 102-107
12. Macdougall IC, Cavill I, Hulme B et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med J 1992; 304: 225-226
13. Ahmed U, Fadia A, Baskin S, Lasker N. What is the best laboratory indicator of iron availability in hemodialysis patients? J Am Soc Nephrol 1993; 4: 423
14. Brock JH. Iron in infection, immunity, inflammation and neoplasia. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds). Iron Metabolism in Health and Disease. Saunders, London, 1994; 353-390
15. Eschbach JW, Cook JD, Scribner BH, Finch CA. Iron balance in hemodialysis patients. Ann Intern Med 1977; 87: 710-713
16. Bezwoda VR, Derman DP, Bothwell TH et al. Iron absorption in patients on regular dialysis therapy. Nephron 1981; 28: 289-293
17. Milman N. Iron absorption in patients with chronic uraemia. Scand J Haematol 1982; 29: 5-17
18. Hussein S, Prieto J, O'Shea M, Hoffbrand AV, Baillod RA, Moorhead JF. Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J 1975; 1: 546-548
19. Donnelly SM, Posen GA, Ali MAM. Oral iron absorption in hemodialysis patients treated with erythropoietin. Clin Invest Med 1991; 14: 271-276
20. Goch J, Birgegard G, Danielson B, Wilkström B. Iron absorption in patients with chronic uremia on maintenance hemodialysis and in healthy volunteers measured with a simple oral iron load test. Nephron 1996; 73: 403-406
21. Cavill I. Diagnostic methods. Clin Haematol 1982; 11: 259-273
22. Braun J, Hammerschmidt M, Schreiber M, Heidler R, Hörl WH. Is zinc protoporphyrin an indicator of iron-deficient erythropoiesis in maintenance haemodialysis patients? Nephrol Dial Transplant 1996; 11: 492-497
23. Weber J, Werre JM, Julius HW, Marx JJM. Decreased iron absorption in patients with active rheumatoid arthritis with and without iron deficiency. Ann Rheum Dis 1988; 47: 404-409
24. Cannata JB, Gomez-Alonso C, Fernandez Menandez MJ et al. Iron uptake in aluminium overload: in vivo and in vitro studies. Nephrol Dial Transplant 1991; 6: 637-642